Shared Biomarker Profiles and Proteomic Insights in Neurodegenerative Diseases
The GNPC identified a shared five-protein biomarker profile across Alzheimer's, Parkinson's, frontotemporal dementia, and ALS, which predicts APOE ε4 status with high accuracy, offering new avenues for understanding and potentially treating these diseases, though causality remains unproven.